Advocacy intelligence hub — real-time data for patient organizations
Gonal-F: FDA approved
For the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Gonal-F
EMD Serono, Inc.
Gonal-F
(Follitropin alfa, recombinant)Orphan drugEMD Serono, Inc.
12.1 Mechanism of Action GONAL-f stimulates ovarian follicular growth in women who do not have primary ovarian failure. In order to bring about final ...
Browse all Endocrinopathy with congenital hypogonadotropic hypogonadism as a major feature news →